ESC Premium Access

Angiotensin converting enzyme 2 activity predicts outcome in heart failure with preserved ejection fraction

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Congress Presentation

About the speaker

Ms Christina Binder

Medical University of Vienna, Vienna (Austria)
2 presentations
0 follower

14 more presentations in this session

Appropriate hemoglobin levels in HFpEF patients: results of Japanese heart failure syndrome with preserved ejection fraction (JASPER) registry

Speaker: Doctor K. Okuno (Philadelphia, US)

Thumbnail

Impact of left ventricular pressure overload on relaxation and stiffness in patients with preserved ejection fraction: noninvasive study using speckle tracking echocardiography

Speaker: Doctor S. Minatoguchi (Gifu, JP)

Thumbnail

Cyclic guanosine monophosphate enhancing therapeutic strategy for heart failure with preserved ejection fraction (cGETS study): effects on cardiac dysfunction and remodeling.

Speaker: Doctor E. Dal Canto (Utrecht, NL)

Thumbnail

Renin activity is an independent predictor of outcome in patients with heart failure and preserved ejection fraction independent of RAAS blocker therapy

Speaker: Ms C. Binder (Vienna, AT)

Thumbnail

Extracellular volume fraction measured by cardiac magnetic resonance imaging can help to evaluate left ventricular stiffness noninvasively by representing histological collagen volume fraction

Speaker: Doctor T. Omori (Tsu , Mie, JP)

Thumbnail

Access the full session

Poster Session 6 - Chronic heart failure – pathophysiology and mechanisms

Speakers: Ms C. Binder, Doctor K. Okuno, Doctor S. Minatoguchi, Doctor E. Dal Canto, Ms C. Binder...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations